Keliximab [174722-30-6]

TargetMol Chemicals

Keliximab

9

174722-30-6

Antibody

Research Use Only

Keliximab

Keliximab (SB-210396), a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody, demonstrates a binding affinity for soluble CD4 with a K i value of 1.0 nM. It inhibits T cell proliferation and IL-2 production, making it a valuable agent for cancer research [1] [2].

3 years

-20°C

12352203